惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园_首页
量子位
D
DataBreaches.Net
博客园 - 司徒正美
J
Java Code Geeks
博客园 - 【当耐特】
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
aimingoo的专栏
aimingoo的专栏
B
Blog
The Cloudflare Blog
D
Docker
I
InfoQ
爱范儿
爱范儿
MongoDB | Blog
MongoDB | Blog
腾讯CDC
月光博客
月光博客
Hugging Face - Blog
Hugging Face - Blog
Microsoft Azure Blog
Microsoft Azure Blog
Vercel News
Vercel News
阮一峰的网络日志
阮一峰的网络日志
小众软件
小众软件
S
SegmentFault 最新的问题
GbyAI
GbyAI
有赞技术团队
有赞技术团队

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Azenta, Inc. (AZTA) Q2 2026 Earnings Call Transcript
2026-05-07 · via All Articles on Seeking Alpha

Q2: 2026-05-05 Earnings Summary

EPS of -$0.04 misses by $0.18

 | 

Revenue of

$144.80M

(0.96% Y/Y)

misses by $3.62M

Azenta, Inc. (AZTA) Q2 2026 Earnings Call May 6, 2026 8:30 AM EDT

Company Participants

Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations
John P. Marotta - President, CEO & Director
Lawrence Lin - Executive VP & CFO

Conference Call Participants

David Saxon - Needham & Company, LLC, Research Division
Matthew Stanton - Jefferies LLC, Research Division
Steven Etoch - Stephens Inc., Research Division
Vijay Kumar - Evercore ISI Institutional Equities, Research Division
Paul Knight - KeyBanc Capital Markets Inc., Research Division
Brendan Smith - TD Cowen, Research Division

Presentation

Operator

Greetings, and welcome to Azenta's Q2 2026 Fiscal Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, May 6, 2026.

I will now turn the conference over to Yvonne Perron, Vice President, FP&A and Investor Relations. Please go ahead.

Yvonne Perron
Vice President of Financial Planning & Analysis and Investor Relations

Thank you, operator, and good morning to everyone on the line today. We would like to welcome you to our earnings conference call for the second quarter of fiscal year 2026.

Our second quarter earnings press release was issued yesterday after market and is available on our Investor Relations website located at investors.azenta.com in addition to the supplementary information and PowerPoint slides that will be used during the prepared remarks today.

Please note that, effective the first fiscal quarter of 2025, the results of B Medical Systems are treated as discontinued operations.

I would like to remind everyone that during the course of the call, we will be making a number of forward-looking statements within the meaning of the Private Litigation Securities Act of 1995. There are many factors that may cause actual financial results or other events to differ from those identified in such forward-looking statements.

I would refer you to the section